Menu
MapConnectionsTopicsBulgariaThe Night (K-TRIO)Marie Skłodowska-CurieFor studentsFor teachersMethodologySurprise me
HEDoctoral network2023–2027

ACTIVA · Advanced Customized Technologies for Intact Vision in Ageing

Horizon Europe — Marie Skłodowska-Curie Actions

Duration
2023-09-01 → 2027-08-31
EU contribution
€2,425,514
Participants
9
Scheme
HORIZON-TMA-MSCA-DN

Lines connect the coordinator with its partners.

Results in brief

Advanced Customized Technologies for Intact Vision in Ageing

The doctoral network ACTIVA – Advanced Customized Technologies for Intact Vision in Ageing – is dedicated to tackling one of Europe’s major health and societal challenges: enabling the elderly to remain active and independent by preserving good vision throughout life. As our population ages, millions of people are affected by natural changes in the eye and by age-related ocular diseases. These conditions impair near and far vision and thereby reduce independence and mobility; in severe cases they can even lead to vision loss. Beyond the impact on the individual, this also places a heavy socio-economic burden on healthcare systems and society at large. ACTIVA addresses this challenge by creating an international, interdisciplinary research platform to develop novel optical technologies for early diagnosis of eye diseases and for compensating age-related changes in vision. Through this network, nine early-stage researchers develop optical solutions that help older adults maintain independence, mobility, and quality of life, while simultaneously gaining the skills needed to drive innovation and become future leaders in vision science. These optical solutions primarily focus on improving near vision, without hampering distance vision, and on enabling early detection of pathological changes, providing practical tools that can be applied in clinical settings. By integrating academic excellence, industrial expertise, and international collaboration, ACTIVA combines cutting-edge research with real-world applications to translate scientific discoveries into technologies that directly benefit the ageing population by reducing the risk of vision loss. In doing so, the network supports European strategies on active and healthy ageing, innovation, and social well-being.

Data: CORDIS, © European Union

Project objective

The proposed DN “Advanced Customized Technologies for Intact Vision in Ageing” (ACTIVA) provides an international, interdisciplinary platform to train young scientists at the interface of physics and medicine to study unresolved questions and develop novel techniques to facilitate intact, or even improved, visual function in the elderly population. Good vision throughout life is a key factor both on a personal level and socioeconomically and has particular pertinence to the ageing population of Europe.ACTIVA is a joint initiative to develop new optical technologies that will facilitate good vision throughout life. Within the project, 9 young researchers will be trained in new optical technologies to diagnose and compensate for different aspects of the normal ageing of the eye as well as the most common age-related ocular conditions. The novel vision enabling techniques, to be developed in this DN, will focus on facilitating the functionality of both near and far vision. Furthermore, early diagnosis of ocular diseases is essential to offer timely treatment and reduce the risk of vision loss. The novel diagnosis technologies, to be developed in this DN, will focus on early detection of pathological changes in visual function. The consortium combines the expertise of three academic partners with excellent research and teaching records and two fully integrated private sector partners. Furthermore, the consortium will be counselled by a scientifically accomplished External Advisory Board. Close collaborations and multi-site training activities will ensure to provide the young researchers with a vast network and interdisciplinary research experience. ACTIVA will be recognized worldwide as a major contribution to the ageing challenge and the social investment of the European Commission in active ageing.

Original text from CORDIS.

Participants

  • KUNGLIGA TEKNISKA HOEGSKOLAN · StockholmCoordinatorSweden
  • Alcon Laboratories Ireland Ltd · Cork, IrelandIreland
  • CARL ZEISS VISION INTERNATIONAL GMBH · AalenGermany
  • DIESTIA SYSTIMATA IDIOTIKI KEFALAIOUCHIKI ETAIREIA · ATHINAGreece
  • EBERHARD KARLS UNIVERSITAET TUEBINGEN · TuebingenGermany
  • TOBII AB · DanderydSweden
  • UNIVERSIDAD DE MURCIA · MurciaSpain
  • UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN · DublinIreland
  • VOPTICA S.L. · MurciaSpain

Links

Data: CORDIS, © European Union